DongSheng Guo, PhD

Dr. DongSheng Guo leads commercialization of Precedo’s precision-medicine technology platforms and oversees market development for cell-culture reagents, including tumor organoids and core raw materials. His background integrates organizational psychology with technology-platform operations and strategic market expansion.

▪ Leads commercialization and market strategy for precision-medicine platforms

▪ Oversees organoid and cell-culture reagent operations

▪ Ph.D., Organizational Psychology, Neill Institute (U.S.)